Sensitivity analyses for radiographic progression-free survival (rPFS): Results from the phase 3 PREVAIL trial comparing enzalutamide to placebo Meeting Abstract
| Authors: | Morris, M. J.; Loriot, Y.; Beer, T. M.; Higano, C. S.; Armstrong, A. J.; Sternberg, C. N.; de Bono, J. S.; Tombal, B. F.; Noonberg, S. B.; Mansbach, H. H.; Bhattacharya, S.; Perabo, F.; Phung, D.; Rathkopf, D. E. |
| Abstract Title: | Sensitivity analyses for radiographic progression-free survival (rPFS): Results from the phase 3 PREVAIL trial comparing enzalutamide to placebo |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613203446 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.5054 |
| Notes: | Meeting Abstract: 5054 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
